{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:11:23Z","timestamp":1788541883018,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination for the improvement of Higher Education Personnel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["304457\/2022-1"],"award-info":[{"award-number":["304457\/2022-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["422747\/2021-1"],"award-info":[{"award-number":["422747\/2021-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2019\/19644-1"],"award-info":[{"award-number":["2019\/19644-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2021\/07979-9"],"award-info":[{"award-number":["2021\/07979-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.lfs.2025.124175","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T07:32:56Z","timestamp":1766734376000},"page":"124175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Adiponectin receptor agonist, AdipoRon, reduces the growth of prostate cancer cells and patient-derived organoids"],"prefix":"10.1016","volume":"387","author":[{"given":"Francielle C.","family":"Mosele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Luiza Romano","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilton Jos\u00e9","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Nascimento","family":"Barquilha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio Cesar Damasceno","family":"Mon\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheli Canuto","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio Luis","family":"Felisbino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Triscott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2025.124175_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2025.124175_bb0010","author":"Ferlay"},{"key":"10.1016\/j.lfs.2025.124175_bb0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev.med.080708.082713","article-title":"Biological mechanisms linking obesity and cancer risk: new perspectives","volume":"61","author":"Roberts","year":"2010","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.lfs.2025.124175_bb0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MOU.0000000000000424","article-title":"Obesity and prostate cancer","volume":"27","author":"Bandini","year":"2017","journal-title":"Curr. Opin. Urol."},{"key":"10.1016\/j.lfs.2025.124175_bb0025","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1080\/01635581.2020.1856889","article-title":"Obesity, inflammation, and advanced prostate cancer","volume":"73","author":"Olivas","year":"2021","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.lfs.2025.124175_bb0030","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.annepidem.2007.11.010","article-title":"Dietary patterns identified using factor analysis and prostate cancer risk: a case control study in western Australia","volume":"18","author":"Ambrosini","year":"2008","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.lfs.2025.124175_bb0035","series-title":"StatPearls [Internet]","article-title":"Genetics and obesity. [Updated 2023 Jul 31]","author":"Tirthani","year":"2023"},{"key":"10.1016\/j.lfs.2025.124175_bb0040","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","article-title":"Obesity phenotypes, diabetes, and cardiovascular diseases","volume":"126","author":"Pich\u00e9","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2025.124175_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-019-0386-z","article-title":"Total adiponectin in overweight and obese subjects and its response to visceral fat loss","volume":"19","author":"Gariballa","year":"2019","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.lfs.2025.124175_bb0050","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/pcan.2017.31","article-title":"Periprostatic adipose in fl ammation is associated with high-grade prostate cancer","volume":"20","author":"Gucalp","year":"2017","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.lfs.2025.124175_bb0055","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.22025","article-title":"Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer","volume":"107","author":"Strom","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.lfs.2025.124175_bb0060","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1158\/1078-0432.CCR-04-1977","article-title":"Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy","volume":"11","author":"Strom","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2025.124175_bb0065","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/apha.12246","article-title":"Adipose tissue and its role in organ crosstalk","volume":"210","author":"Romacho","year":"2014","journal-title":"Acta Physiol."},{"key":"10.1016\/j.lfs.2025.124175_bb0070","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.urology.2004.12.053","article-title":"Prostate cancer and adiponectin","volume":"65","author":"Goktas","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.lfs.2025.124175_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2012\/982769","article-title":"Serum adiponectin level and different kinds of cancer: a review of recent evidence","volume":"2012","author":"Izadi","year":"2012","journal-title":"ISRN Oncol."},{"key":"10.1016\/j.lfs.2025.124175_bb0080","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1158\/1055-9965.EPI-06-0621","article-title":"Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study","volume":"16","author":"Michalakis","year":"2007","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.lfs.2025.124175_bb0085","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2025.124175_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jmcb\/mjw011","article-title":"Adiponectin, the past two decades","volume":"8","author":"Wang","year":"2016","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2025.124175_bb0095","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12013-014-9941-4","article-title":"Adiponectin-induced antitumor activity on prostatic cancers through inhibiting proliferation","volume":"70","author":"Gao","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.lfs.2025.124175_bb0100","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.bbrc.2005.12.103","article-title":"Adiponectin as a growth inhibitor in prostate cancer cells","volume":"340","author":"Bub","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2025.124175_bb0105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/pcan.2011.53","article-title":"Adiponectin inhibits oxidative stress in human prostate carcinoma cells","volume":"15","author":"Lu","year":"2012","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.lfs.2025.124175_bb0110","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1159\/000430313","article-title":"MIR-323 inhibits prostate cancer vascularization through adiponectin receptor","volume":"36","author":"Gao","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2025.124175_bb0115","article-title":"Discovery of a novel potent peptide agonist to adiponectin receptor 1","volume":"13","author":"Kim","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2025.124175_bb0120","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1159\/000481732","article-title":"Adiponectin and its receptors are differentially expressed in human tissues and cell lines of distinct origin","volume":"10","author":"Jasinski-Bergner","year":"2018","journal-title":"Obes. Facts"},{"key":"10.1016\/j.lfs.2025.124175_bb0125","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature12656","article-title":"A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity","volume":"503","author":"Okada-Iwabu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2025.124175_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-29901-w","article-title":"An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis","volume":"8","author":"Yamashita","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2025.124175_bb0135","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1681\/ASN.2017060627","article-title":"The adiponectin receptor agonist AdipoRon ameliorates diabetic nephropathy in a model of type 2 diabetes","volume":"29","author":"Kim","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2025.124175_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115569","article-title":"Adiporon and other adiponectin receptor agonists as potential candidates in cancer treatments","volume":"22","author":"Nigro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2025.124175_bb0145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41419-018-0851-z","article-title":"Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1 ERK- dependent necroptosis","volume":"9","author":"Akimoto","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2025.124175_bb0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11010-019-03586-9","article-title":"Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells","volume":"461","author":"Ramzan","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lfs.2025.124175_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/7262479","article-title":"AdipoRon affects cell cycle progression and inhibits proliferation in human osteosarcoma cells","volume":"2020","author":"Sapio","year":"2020","journal-title":"J. Oncol."},{"key":"10.1016\/j.lfs.2025.124175_bb0160","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.21873\/anticanres.16933","article-title":"The role of adipocytokines and their receptors in prostate cancer: adiponectin may protect against progression","volume":"44","author":"Kashiwagi","year":"2024","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lfs.2025.124175_bb0165","article-title":"Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets","volume":"376","author":"Tang","year":"2022","journal-title":"Science (1979)"},{"key":"10.1016\/j.lfs.2025.124175_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04495-z","article-title":"Patient derived organoids to model rare prostate cancer phenotypes","volume":"9","author":"Puca","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2025.124175_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.lfs.2025.124175_bb0180","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.lfs.2025.124175_bb0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.beem.2013.09.003","article-title":"Adiponectin receptors: a review of their structure, function and how they work","volume":"28","author":"Yamauchi","year":"2014","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"16","key":"10.1016\/j.lfs.2025.124175_bb0190","doi-asserted-by":"crossref","first-page":"8974","DOI":"10.3390\/ijms22168974","article-title":"PPARs-orchestrated metabolic homeostasis in the adipose tissue","volume":"22","author":"Sun","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2025.124175_bb0195","series-title":"Peroxisome Proliferator-activated Receptors and Their Ligands: Nutritional and Clinical Implications \u2013 A Review","first-page":"1","author":"Grygiel-g\u00f3rniak","year":"2014"},{"key":"10.1016\/j.lfs.2025.124175_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.624112","article-title":"PPARgamma in metabolism, immunity, and cancer: unified and diverse mechanisms of action","volume":"12","author":"Hernandez-Quiles","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.lfs.2025.124175_bb0205","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.bbrc.2013.01.105","article-title":"Fenofibrate down-regulates the expressions of androgen receptor (AR) and AR target genes and induces oxidative stress in the prostate cancer cell line LNCaP","volume":"432","author":"Zhao","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"563","key":"10.1016\/j.lfs.2025.124175_bb0210","first-page":"e1","article-title":"Targeting the PI3K-AKT-mTOR pathway in castration resistant prostate cancer: a review article","volume":"19","author":"Cham","year":"2021","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.lfs.2025.124175_bb0215","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","article-title":"Cancer cell metabolism: Warburg and beyond","volume":"134","author":"Hsu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2025.124175_bb0220","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0022-5347(01)66366-3","article-title":"Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose","volume":"155","author":"Effert","year":"1996","journal-title":"J. Urol."},{"key":"10.1016\/j.lfs.2025.124175_bb0225","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.bbalip.2013.03.010","article-title":"The fat side of prostate cancer","volume":"1831","author":"Zadra","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2025.124175_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/biom12121891","article-title":"Calcium overload and mitochondrial metabolism","volume":"12","author":"Walkon","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.lfs.2025.124175_bb0235","first-page":"1","article-title":"Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells","volume":"13","author":"Manley","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2025.124175_bb0240","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.4547","article-title":"A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy","volume":"236","author":"Pertega-Gomes","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.lfs.2025.124175_bb0245","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-1759(88)90310-9","article-title":"A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity","volume":"15","author":"Decker","year":"1988","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.lfs.2025.124175_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16152633","article-title":"Adiponectin receptor agonist AdipoRon inhibits proliferation and drives glycolytic dependence in non-small-cell lung cancer cells","volume":"16","author":"Kafeel","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lfs.2025.124175_bb0255","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1530\/ERC-20-0297","article-title":"Adiponectin receptor activation inhibits prostate cancer xenograft growth","volume":"27","author":"Philp","year":"2020","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.lfs.2025.124175_bb0260","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tcb.2016.08.009","article-title":"Fueling the cell division cycle","volume":"27","author":"Salazar-Roa","year":"2017","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.lfs.2025.124175_bb0265","doi-asserted-by":"crossref","first-page":"42","DOI":"10.20517\/2394-4722.2018.35","article-title":"Genomic heterogeneity meets cellular energetics: crosstalk between the mitochondria and the cell cycle","volume":"4","author":"Herrera","year":"2018","journal-title":"J. Cancer Metastasis Treat."},{"key":"10.1016\/j.lfs.2025.124175_bb0270","first-page":"15","article-title":"Clonogenic assay: adherent cells","author":"Rafehi","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.lfs.2025.124175_bb0275","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nprot.2016.006","article-title":"Organoid culture systems for prostate epithelial and cancer tissue","volume":"11","author":"Drost","year":"2016","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.lfs.2025.124175_bb0280","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525008112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525008112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T05:06:10Z","timestamp":1769490370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525008112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":56,"alternative-id":["S0024320525008112"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.124175","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adiponectin receptor agonist, AdipoRon, reduces the growth of prostate cancer cells and patient-derived organoids","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.124175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124175"}}